Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit.
about
Leukodepletion for patients undergoing heart valve surgeryLeukodepletion for patients undergoing heart valve surgeryCardiopulmonary interactions in healthy children and children after simple cardiac surgery: the effects of positive and negative pressure ventilationObstacles in haemocompatibility testingMinimally invasive coronary artery bypass grafting decreases hospital stay and cost.Autonomous magnetically actuated continuous flow microimmunofluorocytometry assay.Circulatory support for OPCAB procedures.A novel minimal invasive mouse model of extracorporeal circulation.Plasma acetate, gluconate and interleukin-6 profiles during and after cardiopulmonary bypass: a comparison of Plasma-Lyte 148 with a bicarbonate-balanced solution.Induction and detection of disturbed homeostasis in cardiopulmonary bypass.Microfiltration platform for continuous blood plasma protein extraction from whole blood during cardiac surgery.Systolic heart function remains depressed for at least 30 days after on-pump cardiac surgery.Off-pump coronary artery bypass graft surgery: where should we stand?Impact of modified ultrafiltration on morbidity after pediatric cardiac surgery.Resting energy expenditure after Fontan surgery in children with single-ventricle heart defectsSystemic angiopoietin-1/2 dysregulation following cardiopulmonary bypass in adults.Effect of methylprednisolone on the oxidative burst activity, adhesion molecules and clinical outcome following open heart surgery.Cardiopulmonary bypass and the adaptive immune system: perspectives on T cell function.High-sensitivity C-reactive protein (hs-CRP) and tumor necrotizing factor-alpha (TNF-alpha) after on- and off- pump coronary artery bypass grafting.Comparison of inflammatory response following coronary revascularization with or without cardiopulmonary bypassContinuous monitoring of inflammation biomarkers during simulated cardiopulmonary bypass using a microfluidic immunoassay device - a pilot study.Clinical role of blood heparin level monitoring during open heart surgery.Pre-operative and intraoperative determinants for prolonged ventilation following adult cardiac surgery.Changes in the plasma protease systems during open-heart surgery with dextran vs. Ringer acetate as priming solution.The influence of a heparin-coated oxygenator during cardiopulmonary bypass on postoperative lung oxygenation capacity in pediatric patients with congenital heart anomalies.Effect of cardiopulmonary bypass on leukocyte activation: changes in membrane-bound elastase on neutrophils.Impact of Early Postoperative Hydrocortisone Administration in Cardiac Surgical Patients After Cardiopulmonary Bypass.ICU outcomes in adult cardiac surgery patients in relation to ultrafiltration type.Neurological damage due to coagulation and fat release during cardiopulmonary bypass.The spectrum of myocardial homeostasis mechanisms in the settings of cardiac surgery procedures (Review).The impact of the pro- and anti-inflammatory immune response on ventilation time after cardiac surgery.Cytokine and S100B levels in paediatric patients undergoing corrective cardiac surgery with or without total circulatory arrest.A lipopolysaccharide adsorber in adult cardiopulmonary bypass: a single centre randomised controlled pilot trial.White matter injury and the inflammatory response following neonatal cardiac surgery.A microfluidic device for continuous, real time blood plasma separation.Continuous cytometric bead processing within a microfluidic device for bead based sensing platforms.Equivalence of the acute cytokine surge and myocardial injury after coronary artery bypass grafting with and without a novel extracorporeal circulation system.Inter-individual differences in cytokine release in patients undergoing cardiac surgery with cardiopulmonary bypass.Endogenous morphine is produced in response to cardiopulmonary bypass in neonatal pigs.Perioperative serum levels of tumour-necrosis-factor alpha (TNF-alpha), IL-1 beta, IL-6, IL-10 and soluble IL-2 receptor in patients undergoing cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution.
P2860
Q24200962-FB51E569-FA46-4A52-91F3-272467DD847DQ24234849-A0C3200A-CED5-4A64-B6BF-2E090773A899Q24672558-EFD63A2C-29AE-4A71-A674-92DAA9028E3EQ27004486-A45B3FE0-6F5E-46EA-B71F-22E363001ED8Q30470777-39FBFF62-E904-4A6D-85DB-A87A804B490EQ34046781-45428C40-3257-4BB9-B5FF-6BBFE37EDCB7Q34760383-C42AB307-1F5A-4DB8-9AAD-85AE68343977Q35075271-A8105740-CF68-404D-811D-122982C61DE3Q35567213-BB176C57-F0F1-4083-8835-8E7D752B811AQ35929339-D746DDE1-CB9E-420E-8828-0AE7AD56B668Q35961102-0C5D5949-BBAE-447C-B673-05A2D0D4C4F2Q36175529-9D29386D-DE81-467C-9F74-310AA903269BQ36314843-DA55B4F8-2126-46AF-A2FC-CE5B80E6A32AQ36546949-52FDC74B-27CA-4606-9211-48F9AB646C02Q37019445-5EE8149D-81F0-4320-881E-E6CC7609D545Q37701742-A7986629-F1C2-46CF-A16F-7DB1203B245FQ40657659-82F84805-8C6D-4969-A540-0799AC2FA31CQ41118936-4C92BC59-4543-4DAA-920F-5F87AC8A0E57Q41623499-262313FF-88D5-4553-B754-C6ECF2A937ACQ41865603-5E850449-69A5-4188-89DA-ED5AED5F02D2Q42137581-7100E4B1-F727-4423-B9B2-842402AB0902Q42618191-630D5319-5CE6-4313-8520-3F2A5D87A610Q42625316-EA468F5B-6811-4C87-B51A-2B1D9C62AB85Q42639849-00B0697E-8951-4BFC-8C79-92153F732A6CQ44470910-D092DB7B-77BE-4A78-917F-0D8A7A1D921EQ44910354-8072FA95-28B2-43B7-899B-3353B7A5EF65Q44963058-66CC5980-ECEB-4911-AA65-069B2C6FAC4FQ46591994-48BEA767-6778-4804-9295-ABC5DC4C332FQ46934151-CEC53D19-56FF-4CAD-A503-E6908212D28BQ47569390-590A9D65-5357-40B8-8628-B4F51EB466DDQ47949352-D4832BFD-6EE8-4C38-A8D4-BF5BFAE3F19EQ48131102-FD988F08-6C2D-4EFD-8535-4D5F054F708FQ48367040-31E98E15-AFA6-40BB-957F-916FCBDE04AAQ48369693-8A1A573B-A6D4-47C5-A4DD-E42B1DDA96C2Q50730288-3420B3FE-0A6E-465D-BB69-77B6FC63708AQ51013228-F13C8E9B-5F0E-47FC-80F6-F2CF7EABAD07Q51231871-FA24B131-6004-43B8-8C6B-457606A97C8BQ51351804-19994F87-0A21-46F5-B875-F8100D6696DFQ51373324-727BCA49-01ED-478C-97A8-779E56B46B1EQ51434203-958A5D76-5656-4653-83EF-6AAF0E45EF61
P2860
Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Organ dysfunction after cardio ...... by the extracorporeal circuit.
@en
Organ dysfunction after cardio ...... by the extracorporeal circuit.
@nl
type
label
Organ dysfunction after cardio ...... by the extracorporeal circuit.
@en
Organ dysfunction after cardio ...... by the extracorporeal circuit.
@nl
prefLabel
Organ dysfunction after cardio ...... by the extracorporeal circuit.
@en
Organ dysfunction after cardio ...... by the extracorporeal circuit.
@nl
P356
P1476
Organ dysfunction after cardio ...... by the extracorporeal circuit.
@en
P2093
P2888
P356
10.1007/BF00254791
P577
1987-01-01T00:00:00Z